QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Quinapril Hydrochloride And Hydrochlorothiazide patents expire, and when can generic versions of Quinapril Hydrochloride And Hydrochlorothiazide launch?
Quinapril Hydrochloride And Hydrochlorothiazide is a drug marketed by Apotex, Aurobindo Pharma, Chartwell Rx, Invagen Pharms, Norvium Bioscience, and Sun Pharm Inds Ltd. and is included in six NDAs.
The generic ingredient in QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; quinapril hydrochloride. There are thirty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; quinapril hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
- What are the global sales for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
- What is Average Wholesale Price for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
Summary for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 4 |
| Clinical Trials: | 7 |
| What excipients (inactive ingredients) are in QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE? | QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE excipients list |
| DailyMed Link: | QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE at DailyMed |
Recent Clinical Trials for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| LaborMed Pharma S.A. | Phase 4 |
| Vanderbilt University Medical Center | Phase 4 |
| National Center for Research Resources (NCRR) | Phase 4 |
See all QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE clinical trials
Pharmacology for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
| Drug Class | Angiotensin Converting Enzyme Inhibitor Thiazide Diuretic |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
| Physiological Effect | Increased Diuresis |
US Patents and Regulatory Information for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex | QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; quinapril hydrochloride | TABLET;ORAL | 091524-001 | Mar 12, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm Inds Ltd | QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; quinapril hydrochloride | TABLET;ORAL | 078211-003 | Mar 4, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell Rx | QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; quinapril hydrochloride | TABLET;ORAL | 076374-001 | Mar 31, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
